NCT03834090

Brief Summary

No consensus has yet been built on the treatment of lateral epicondylitis (LE) due to the lack of evidence. Although conflicting results are present, radial extracorporeal shock wave therapy (rESWT) has increasingly been used in the treatment of tendinopathy

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 20, 2015

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2015

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2016

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

February 5, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 7, 2019

Completed
Last Updated

February 7, 2019

Status Verified

February 1, 2019

Enrollment Period

6 months

First QC Date

February 5, 2019

Last Update Submit

February 6, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change Patient-rated Tennis Elbow Evaluation score

    The Patient-rated Tennis Elbow Evaluation is a specific questionnaire designed for the evaluation of the disease-specific pain and function/disability in LE. The scores were calculated separately and as the total PRTEE score, where 0 represented the best score, and 100 represented the worst score. The PRTEE consists of a pain scale with 5 items questioning pain during rest and specific activities (0 represents 'no pain' and 10 represents 'the highest pain'), and a function/disability scale with 10 items evaluating difficulties experienced during specific and daily activities (0 represents 'no difficulty' and 10 represents 'the highest difficulty)

    Change from Baseline at 1 month and 3 months after treatment.

Secondary Outcomes (3)

  • Change Visual Analogue Scale score

    Change from Baseline at 1 month and 3 months after treatment.

  • Change Roles and Maudsley Score

    Change from Baseline at 1 month and 3 months after treatment.

  • Change Grip Strength score

    Change from Baseline at 1 month and 3 months after treatment.

Study Arms (2)

rESWT

EXPERIMENTAL

the group receiving rESWT

Device: rESWT

supervised exercises

ACTIVE COMPARATOR

the group receiving supervised exercises

Other: Supervised exercises

Interventions

rESWTDEVICE

rESWT was administered once per week for 3 weeks using a ShockMaster 500 device with 1.8 bar pneumatic pressure, 10 Hz frequency, with 2000 pulses.

rESWT

A program including post-isometric relaxation, and progressive resistance exercise (eccentric wrist extension) on the wrist extensors

supervised exercises

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The diagnosis of LE was made in the clinical examination, and the diagnosis was confirmed with the Southampton Diagnostic Criteria of "the presence of epicondyle pain, and epicondyle pain and tenderness on resisted extension of the wrist.
  • Patients with symptoms lasting longer than 3 months
  • with average pain in the previous week detected as 3 or above on a 10-cm visual analogue scale (VAS)
  • who were aged over 18 years

You may not qualify if:

  • pain in the proximal part of the affected extremity (e.g. shoulder pain, neck pain)
  • abnormal neurogenic symptoms (e.g. radicular pain, numbness) on the affected extremity
  • presence of posterior interosseous nerve entrapment
  • congenital or acquired upper extremity deformities that might affect grip strength
  • systemic musculoskeletal system or neurologic disorders
  • systemic rheumatologic disease or systemic infection
  • presence of malignancy, coagulation disorders, and anticoagulant use
  • inserted cardiac pacemaker
  • history of surgical treatment on the elbow of the affected extremity
  • pregnancy.
  • patients who were administered other treatments such as physical therapy or steroid injections in the last 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Tennis Elbow

Condition Hierarchy (Ancestors)

Elbow TendinopathyTendinopathyMuscular DiseasesMusculoskeletal DiseasesElbow InjuriesArm InjuriesWounds and InjuriesTendon Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 5, 2019

First Posted

February 7, 2019

Study Start

February 20, 2015

Primary Completion

August 15, 2015

Study Completion

January 15, 2016

Last Updated

February 7, 2019

Record last verified: 2019-02